Dr. John Stuart Yordy, M.D. , PH.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 2490 S Woodworth Loop Ste 150, Palmer, AK 99645 Phone: 907-745-2900 Fax: 907-745-2999 |
Dr. Scott Robert Naspinsky, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 2280 S Woodworth Loop, Palmer, AK 99645 Phone: 907-746-4646 Fax: 907-746-4653 |
Kelly Powers, Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 2280 S Woodworth Loop, Palmer, AK 99645 Phone: 907-746-4646 Fax: 907-746-4653 |
News Archive
Attitudes of Singaporeans and permanent residents toward gays and lesbians although sharply polarised and predominantly negative, have shifted slightly over a five-year span to become a little more favourable. This was found by a research team from the Wee Kim Wee School of Communication and Information at Nanyang Technological University (NTU).
A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014 Taubman Prize for Excellence in Translational Medical Science, awarded by the A. Alfred Taubman Medical Research Institute at the University of Michigan Medical School.
Affymetrix, Inc. today announced that the U. S. Court of Appeals for the Federal Circuit has affirmed the dismissal of the patent infringement lawsuits brought against the Company by Illumina regarding U.S. Patent Nos. 7,510,841 and 7,612,020.
Kaiser Permanente's National Pharmacy Programs and Services was recognized at the J.D. Power and Associates Customer Service Roundtable in Las Vegas as a J.D. Power 2011 Customer Service Champion — one of only 40 companies to have earned the distinction this year.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
› Verified 7 days ago